Canada - English - Health Canada

pfizer canada ulc - somatropin - powder for solution - 1.2mg - somatropin 1.2mg - pituitary

Canada - English - Health Canada

pfizer canada ulc - somatropin - powder for solution - 1.4mg - somatropin 1.4mg - pituitary

Canada - English - Health Canada

pfizer canada ulc - somatropin - powder for solution - 1.6mg - somatropin 1.6mg - pituitary

Canada - English - Health Canada

pfizer canada ulc - somatropin - powder for solution - 1.8mg - somatropin 1.8mg - pituitary

Canada - English - Health Canada

pfizer canada ulc - somatropin - powder for solution - 2mg - somatropin 2mg - pituitary

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma limited - human plasma protein - solution for infusion - %v/v - blood substitutes and plasma protein fractions

European Union - English - EMA (European Medicines Agency)

actavis group ptc ehf - reteplase - myocardial infarction - antithrombotic agents - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

Canada - English - Health Canada

octapharma pharmazeutika produktionsges m b h - human plasma proteins - solution - 14g - human plasma proteins 14g - hemostatics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

octapharma ltd - human plasma proteins - infusion - 57.5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

octapharma ltd - human plasma proteins - infusion - 57.5mg/1ml